{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:12:01Z","timestamp":1779275521495,"version":"3.51.4"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Xinjiang Uygur Autonomous Region Natural Science Fund","award":["2022D01C238"],"award-info":[{"award-number":["2022D01C238"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81660032"],"award-info":[{"award-number":["81660032"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81060050"],"award-info":[{"award-number":["81060050"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Translational Research Project of the National Clinical Research Center for Hematological Diseases","award":["2021 WWC03"],"award-info":[{"award-number":["2021 WWC03"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,31]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Hemophagocytic lymphohistiocytosis (HLH) is a severe immune dysregulation syndrome. Hepatitis-associated severe aplastic anemia (SAA) is a specific subtype of acquired aplastic anemia characterized by concomitant hepatitis, leading to a challenging diagnosis and poor prognosis. Here, we present a rare case of HLH in the context of hepatitis-associated SAA, emphasizing the need for early recognition and individualized management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>The patient, a 19-year-old male, presented with recurrent fever, jaundice, and cytopenias, indicative of hepatitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>\n                      Bone marrow aspiration and biopsy suggested SAA, while peripheral blood next-generation sequencing detected\n                      <jats:italic toggle=\"yes\">Candida tropicalis<\/jats:italic>\n                      infection on 2 separate occasions. Despite combination antifungal therapy with amphotericin B and posaconazole, the bilirubin level continued to rise. Additional tests revealed an elevated soluble CD25 level of 3659 U\/mL, decreased natural killer cell activity of 1.8%, and a serum ferritin level\u2005&gt;\u20052000 \u03bcg\/L. The final diagnosis was HLH.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Dexamethasone and ruxolitinib were administered to control the fever. Subsequently, the patient underwent HLA-matched allogeneic bone marrow and peripheral blood hematopoietic stem cell transplantation for SAA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The patient\u2019s symptoms, including fever and fatigue, resolved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case highlights that HLH should be considered in SAA patients with unexplained fever, poor response to anti-infectives, and elevated bilirubin. A treatment strategy addressing both bone marrow failure and hyperinflammation is essential. In this patient, allogeneic hematopoietic stem cell transplantation served as a successful curative intervention by targeting the shared pathophysiology of HLH and SAA. However, given the inherent limitations of a single case, the generalizability of our findings and the efficacy of allogeneic hematopoietic stem cell transplantation require validation through larger, controlled studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000045430","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:02:48Z","timestamp":1763571768000},"page":"e45430","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Hemophagocytic lymphohistiocytosis in the context of hepatitis-associated severe aplastic anemia: A case report"],"prefix":"10.1097","volume":"104","author":[{"given":"Jianli","family":"Xu","sequence":"first","affiliation":[{"name":"Hematologic Disease Center, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China"},{"name":"Xinjiang Uygur Autonomous Region Research Institute of Hematology, Urumqi, Xinjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailong","family":"Yuan","sequence":"additional","affiliation":[{"name":"Hematologic Disease Center, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China"},{"name":"Xinjiang Uygur Autonomous Region Research Institute of Hematology, Urumqi, Xinjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[{"name":"Hematologic Disease Center, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China"},{"name":"Xinjiang Uygur Autonomous Region Research Institute of Hematology, Urumqi, Xinjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Qu","sequence":"additional","affiliation":[{"name":"Hematologic Disease Center, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China"},{"name":"Xinjiang Uygur Autonomous Region Research Institute of Hematology, Urumqi, Xinjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Wang","sequence":"additional","affiliation":[{"name":"Hematologic Disease Center, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China"},{"name":"Xinjiang Uygur Autonomous Region Research Institute of Hematology, Urumqi, Xinjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Chen","sequence":"additional","affiliation":[{"name":"Hematologic Disease Center, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China"},{"name":"Xinjiang Uygur Autonomous Region Research Institute of Hematology, Urumqi, Xinjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2956-3461","authenticated-orcid":false,"given":"Ming","family":"Jiang","sequence":"additional","affiliation":[{"name":"Hematologic Disease Center, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China"},{"name":"Xinjiang Uygur Autonomous Region Research Institute of Hematology, Urumqi, Xinjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260520","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R2-20260520","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-pathol-020117-043625","article-title":"Hemophagocytic lymphohistiocytosis.","volume":"13","author":"Al-Samkari","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"R3-20260520","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1182\/blood.2021012764","article-title":"An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis.","volume":"139","author":"Zoref-Lorenz","year":"2022","journal-title":"Blood"},{"key":"R4-20260520","first-page":"38","article-title":"Aplastic anemia presenting as hemophagocytic lymphohistiocytosis.","volume":"27","author":"Celkan","year":"2010","journal-title":"Turk J Haematol"},{"key":"R5-20260520","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/apm.12308","article-title":"Ileal mass-like lesion induced by Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in a patient with aplastic anemia.","volume":"123","author":"Min","year":"2015","journal-title":"APMIS"},{"key":"R6-20260520","first-page":"213","article-title":"Analysis of five cases of hepatitis associated aplastic anemia presenting with hemophagocytic lymphohistiocytosis at onset.","volume":"58","author":"Wei","year":"2020","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"R7-20260520","first-page":"e22411","article-title":"Hemophagocytic lymphohistiocytosis and infection: a literature review.","volume":"14","author":"Koumadoraki","year":"2022","journal-title":"Cureus"},{"key":"R8-20260520","doi-asserted-by":"crossref","first-page":"826080","DOI":"10.3389\/fmed.2022.826080","article-title":"Development of a nomogram to predict the risk of chronic active Epstein-Barr virus infection progressing to hemophagocytic lymphohistiocytosis.","volume":"9","author":"He","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R9-20260520","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1743-422X-8-87","article-title":"Hepatitis associated aplastic anemia: a review.","volume":"8","author":"Rauff","year":"2011","journal-title":"Virol J"},{"key":"R10-20260520","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/(SICI)1096-9071(199906)58:2<160::AID-JMV10>3.0.CO;2-9","article-title":"Is hepatitis G\/GB virus-C virus hepatotropic? Detection of hepatitis G\/GB virus-C viral RNA in liver and serum.","volume":"58","author":"Fan","year":"1999","journal-title":"J Med Virol"},{"key":"R11-20260520","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/jmv.21161","article-title":"GB virus type C infection in hemodialysis patients considering co-infection with hepatitis C virus.","volume":"80","author":"Hosseini-Moghaddam","year":"2008","journal-title":"J Med Virol"},{"key":"R12-20260520","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/hep.510290121","article-title":"Dynamics of GB virus C viremia early after orthotopic liver transplantation indicates extrahepatic tissues as the predominant site of GB virus C replication.","volume":"29","author":"Berg","year":"1999","journal-title":"Hepatology"},{"key":"R13-20260520","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/vox.12876","article-title":"Global prevalence of human pegivirus-1 in healthy volunteer blood donors: a systematic review and meta-analysis.","volume":"115","author":"Yang","year":"2020","journal-title":"Vox Sang"},{"key":"R14-20260520","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jmv.25291","article-title":"High prevalence and autochtonous transmission of human pegivirus (HPgV-1) in blood donors in the extreme southern of Brazil.","volume":"91","author":"Da Mota","year":"2019","journal-title":"J Med Virol"},{"key":"R15-20260520","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1537-2995.2004.00665.x","article-title":"High prevalence of GBV-C\/HGV among relatives of GBV-C\/HGV-positive blood donors in blood recipients and in patients with aplastic anemia.","volume":"44","author":"Seifried","year":"2004","journal-title":"Transfusion"},{"key":"R16-20260520","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1743-422X-8-30","article-title":"Hepatitis G virus associated aplastic anemia: a recent case from Pakistan.","volume":"8","author":"Riaz Shah","year":"2011","journal-title":"Virol J"},{"key":"R17-20260520","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1182\/blood.V90.3.1335","article-title":"Prevalence of hepatitis G virus in patients with aplastic anemia.","volume":"90","author":"Kiem","year":"1997","journal-title":"Blood"},{"key":"R18-20260520","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/MPH.0b013e31822bf699","article-title":"A marked decrease in CD4-positive lymphocytes at the onset of hepatitis in a patient with hepatitis-associated aplastic anemia.","volume":"34","author":"Ikeda","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"key":"R19-20260520","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.20102538","article-title":"Hemophagocytosis causes a consumptive anemia of inflammation.","volume":"208","author":"Zoller","year":"2011","journal-title":"J Exp Med"},{"key":"R20-20260520","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s40778-018-0139-3","article-title":"The role of interferon-gamma in hematopoietic stem cell development, homeostasis, and disease.","volume":"4","author":"Morales-Mantilla","year":"2018","journal-title":"Curr Stem Cell Rep"},{"key":"R21-20260520","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.thj.6200340","article-title":"In vitro effects of interferon-gamma and tumor necrosis factor-alpha on CD34+ bone marrow progenitor cells from aplastic anemia patients and normal donors.","volume":"5","author":"Welsh","year":"2004","journal-title":"Hematol J"},{"key":"R22-20260520","doi-asserted-by":"crossref","first-page":"932354","DOI":"10.4061\/2010\/932354","article-title":"Alteration in marrow stromal microenvironment and apoptosis mechanisms involved in aplastic anemia: an animal model to study the possible disease pathology.","volume":"2010","author":"Chatterjee","year":"2010","journal-title":"Stem Cells Int"},{"key":"R23-20260520","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2017-06-788349","article-title":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study.","volume":"130","author":"Bergsten","year":"2017","journal-title":"Blood"},{"key":"R24-20260520","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1080\/15384047.2021.1996139","article-title":"Requirement for containing etoposide in the initial treatment of lymphoma associated hemophagocytic lymphohistiocytosis.","volume":"22","author":"Song","year":"2021","journal-title":"Cancer Biol Ther"},{"key":"R25-20260520","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1159\/000514920","article-title":"The efficacy of etoposide-based therapy in adult secondary hemophagocytic lymphohistiocytosis.","volume":"144","author":"Naymagon","year":"2021","journal-title":"Acta Haematol"},{"key":"R26-20260520","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1182\/blood.2019000761","article-title":"Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis.","volume":"134","author":"Albeituni","year":"2019","journal-title":"Blood"},{"key":"R27-20260520","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood.2021014860","article-title":"A study of ruxolitinib response-based stratified treatment for pediatric hemophagocytic lymphohistiocytosis.","volume":"139","author":"Zhang","year":"2022","journal-title":"Blood"},{"key":"R28-20260520","doi-asserted-by":"crossref","first-page":"E103","DOI":"10.1002\/ajh.26091","article-title":"Ruxolitinib in adult patients with secondary hemophagocytic lymphohistiocytosis.","volume":"96","author":"Boonstra","year":"2021","journal-title":"Am J Hematol"},{"key":"R29-20260520","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/bjh.17331","article-title":"Ruxolitinib-combined doxorubicin-etoposide-methylprednisolone regimen as a salvage therapy for refractory\/relapsed haemophagocytic lymphohistiocytosis: a single-arm, multicentre, phase 2 trial.","volume":"193","author":"Wang","year":"2021","journal-title":"Br J Haematol"},{"key":"R30-20260520","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/hon.3014","article-title":"Outcomes of allogeneic hematopoietic stem cell transplantation for primary hemophagocytic lymphohistiocytosis in adults.","volume":"40","author":"He","year":"2022","journal-title":"Hematol Oncol"},{"key":"R31-20260520","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.13853","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia.","volume":"172","author":"Killick","year":"2016","journal-title":"Br J Haematol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045430","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:04:22Z","timestamp":1779275062000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":31,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045430","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"2025-05-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}